Cinnarizine and sodium valproate as the preventive agents of pediatric migraine: A randomized double-blind placebo-controlled trial
Man Amanat(Tehran University of Medical Sciences), Mahmoud Reza Ashrafi(Children's Medical Center), Mahtab Ramezani(Shahid Beheshti University of Medical Sciences), Ali Reza Tavasoli(Children's Medical Center), Mansoureh Togha(Iran University of Medical Sciences), Reza Azizi Malamiri(Ahvaz Jundishapur University of Medical Sciences), Elmira Agah(University of California, Davis), Fariba Fashandaky(Children's Medical Center), Morteza Heidari(Tehran University of Medical Sciences), Hamid Eshaghi(Children's Medical Center), Mona Salehi(Tehran University of Medical Sciences)
Cited by 16
Related Papers
Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial
|Neurotherapeutics|2018|142
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
|The Lancet Neurology|2020|121
Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study
|EBioMedicine|2020|107